Annual Short Term Debt
$262.00 K
-$154.00 K-37.02%
31 December 2023
Summary:
Leap Therapeutics annual short term debt is currently $262.00 thousand, with the most recent change of -$154.00 thousand (-37.02%) on 31 December 2023. During the last 3 years, it has fallen by -$146.00 thousand (-35.78%). LPTX annual short term debt is now -99.13% below its all-time high of $30.27 million, reached on 31 December 2016.LPTX Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Short Term Debt
$376.00 K
-$67.00 K-15.12%
30 September 2024
Summary:
Leap Therapeutics quarterly short term debt is currently $376.00 thousand, with the most recent change of -$67.00 thousand (-15.12%) on 30 September 2024. Over the past year, it has increased by +$7000.00 (+1.90%). LPTX quarterly short term debt is now -98.76% below its all-time high of $30.27 million, reached on 31 December 2016.LPTX Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LPTX Short Term Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -37.0% | +1.9% |
| 3 y3 years | -35.8% | +16.4% |
| 5 y5 years | +100.0% | -33.6% |
LPTX Short Term Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -39.4% | at low | -15.1% | +43.5% |
| 5 y | 5 years | -44.7% | -33.6% | +43.5% | |
| alltime | all time | -99.1% | -98.8% |
Leap Therapeutics Short Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $376.00 K(-15.1%) |
| June 2024 | - | $443.00 K(+3.0%) |
| Mar 2024 | - | $430.00 K(+64.1%) |
| Dec 2023 | $262.00 K(-37.0%) | $262.00 K(-29.0%) |
| Sept 2023 | - | $369.00 K(-15.4%) |
| June 2023 | - | $436.00 K(+2.6%) |
| Mar 2023 | - | $425.00 K(+2.2%) |
| Dec 2022 | $416.00 K(-3.7%) | $416.00 K(+2.7%) |
| Sept 2022 | - | $405.00 K(+2.5%) |
| June 2022 | - | $395.00 K(+8.8%) |
| Mar 2022 | - | $363.00 K(-16.0%) |
| Dec 2021 | $432.00 K | $432.00 K(+33.7%) |
| Sept 2021 | - | $323.00 K(-8.8%) |
| June 2021 | - | $354.00 K(-15.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2021 | - | $418.00 K(+2.5%) |
| Dec 2020 | $408.00 K(-13.9%) | $408.00 K(+2.5%) |
| Sept 2020 | - | $398.00 K(+2.6%) |
| June 2020 | - | $388.00 K(+2.4%) |
| Mar 2020 | - | $379.00 K(-20.0%) |
| Dec 2019 | $474.00 K(>+9900.0%) | $474.00 K(-16.3%) |
| Sept 2019 | - | $566.00 K(-13.9%) |
| June 2019 | - | $657.00 K(-11.0%) |
| Mar 2019 | - | $738.00 K(>+9900.0%) |
| Dec 2018 | $0.00(-100.0%) | $0.00(0.0%) |
| Sept 2017 | - | $0.00(0.0%) |
| June 2017 | - | $0.00(0.0%) |
| Mar 2017 | - | $0.00(-100.0%) |
| Dec 2016 | $30.27 M(+863.8%) | $30.27 M(+863.8%) |
| Dec 2015 | $3.14 M | $3.14 M |
FAQ
- What is Leap Therapeutics annual short term debt?
- What is the all time high annual short term debt for Leap Therapeutics?
- What is Leap Therapeutics annual short term debt year-on-year change?
- What is Leap Therapeutics quarterly short term debt?
- What is the all time high quarterly short term debt for Leap Therapeutics?
- What is Leap Therapeutics quarterly short term debt year-on-year change?
What is Leap Therapeutics annual short term debt?
The current annual short term debt of LPTX is $262.00 K
What is the all time high annual short term debt for Leap Therapeutics?
Leap Therapeutics all-time high annual short term debt is $30.27 M
What is Leap Therapeutics annual short term debt year-on-year change?
Over the past year, LPTX annual short term debt has changed by -$154.00 K (-37.02%)
What is Leap Therapeutics quarterly short term debt?
The current quarterly short term debt of LPTX is $376.00 K
What is the all time high quarterly short term debt for Leap Therapeutics?
Leap Therapeutics all-time high quarterly short term debt is $30.27 M
What is Leap Therapeutics quarterly short term debt year-on-year change?
Over the past year, LPTX quarterly short term debt has changed by +$7000.00 (+1.90%)